sodium lauriminodipropionate은 임신 중 안전한가요?
No harmonised CLP reproductive classifications (e.g., H360/H361) or SCCS/CIR safety assessments were identified for sodium lauriminodipropionate. Aggregated PubChem GHS notifications (H315, H318, H319) relate to skin/eye irritation but do not indicate reproductive hazard; therefore default hazard and mechanism scores are 0. No peer‑reviewed or regulatory reproductive data were identified in the provided sources (ECHA Annex VI, CIR, SCCS).
성분
sodium lauriminodipropionate
알려진 위험 없음100
/100
0
Pregnancy-safe products containing sodium lauriminodipropionate
Related ingredients
Frequently asked questions
- sodium lauriminodipropionate은 임신 중 안전한가요?
- No harmonised CLP reproductive classifications (e.g., H360/H361) or SCCS/CIR safety assessments were identified for sodium lauriminodipropionate. Aggregated PubChem GHS notifications (H315, H318, H319) relate to skin/eye irritation but do not indicate reproductive hazard; therefore default hazard and mechanism scores are 0. No peer‑reviewed or regulatory reproductive data were identified in the provided sources (ECHA Annex VI, CIR, SCCS).
- sodium lauriminodipropionate은 모유 수유 중 안전한가요?
- Same rationale as pregnancy: no reproductive or lactation-specific toxicity or mechanistic data identified in priority sources. Available GHS notifications indicate irritation endpoints only and are not harmonised classifications. No evidence found to raise concern for effects via breastmilk.
- sodium lauriminodipropionate은 아기 피부에 안전한가요?
- Hazard and mechanism scores remain 0 in absence of reproductive/toxic mechanistic data. Exposure score increased to 1 for infants because although sodium lauriminodipropionate is used topically as a surfactant/conditioning agent and is not reported as systemically acting, infant skin has a higher surface‑area‑to‑weight ratio and a less mature barrier, so topical ingredients with measurable (even low) dermal absorption warrant a conservative +1 exposure for 0–3 yr. No data were found to justify higher exposure or hazard.
- VeriMom은 sodium lauriminodipropionate을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 sodium lauriminodipropionate을 100/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 sodium lauriminodipropionate 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.





